Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
7634.T
Strong BuyHoshi Iryo-Sanki Co., Ltd. · Healthcare · Japan · $103M · Avg Vol: $11K/d
98
StockRankGet insider-trade alerts
Q
66
V
85
M
62
P/E (TTM)
12.1x
ROE
7.1%
D/E
0.1x
Dividend %
1.7%
COMPANY DESCRIPTION
Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan.
FINANCIAL SUMMARY (JPY)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 13.8B | 14.8B | 15.1B | 15.5B | 4.0% | 15.6B |
| EPS (JPY) | 358.33 | 402.98 | 450.70 | 469.18 | 439.30 | 5.2% | 439.37 |
| Shares | — | 3.1M | 3.1M | 3.1M | 3.1M | +0.3% | 3.1M |
| Debt | — | 1.0B | 834.4M | 1.1B | 1.3B | 8.6% | — |
| Equity | — | 15.4B | 17.1B | 18.4B | 20.0B | 9.2% | — |
| Op CF | — | 2.3B | 2.4B | 2.2B | 2.5B | 2.7% | 2.5B |
| Inv CF | — | -1.1B | -744.9M | -5.3B | -1.5B | — | — |
| Fin CF | — | -957.7M | -902.9M | -739.6M | -948.4M | — | — |
Loading 1Y...
PRICE (1Y)+3.9%
SMA 50SMA 200
Close
$33.12
RSI (14)
66.7
52W High
$37.19
From 52W High
0.9%
SCORE BREAKDOWN
Quality
66
ROIC
9.1%70.6
ROE
7.1%63.2
GP/Assets
28.8%63.1
Op. Margin
10.9%66.3
FCF/Assets
7.8%79.4
Piotroski
431.6
Int. Cover
50.0x89.3
D/E Ratio
0.06x68.4
Current Ratio
3.40x59.3
Value
85
P/E (TTM)
12.1x83.3
EV/EBITDA
1.9x98.4
P/FCF
7.9x87.8
P/B
0.8x89.6
P/S
1.1x82.3
Div Yield
1.7%41.3
Momentum
62
52W High %
89%81.0
RS 6M
-11%52.4
SMA 50/200
1.01x62.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
7%45.8
FUNDAMENTALS
Market Cap
$103M
P/E (Forward)
—
Gross Margin
49.5%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 7634.T are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 7634.T | Hoshi Iryo-Sanki Co., Ltd.(you) | $103M | 98 | Strong Buy |
| 9265.T | Yamashita Health Care Holdings,Inc. | $60M | 99 | Strong Buy |
| 2689.T | OLBA HEALTHCARE HOLDINGS, Inc. | $69M | 95 | Strong Buy |
| 3183.T | WIN-Partners Co., Ltd. | $218M | 92 | Strong Buy |
| 3151.T | Vital KSK Holdings, Inc. | $500M | 91 | Strong Buy |
| 7476.T | AS ONE Corporation | $1.1B | 91 | Strong Buy |
| 7459.T | MediPal Holdings Corporation | $3.7B | 94 | Strong Buy |
| 9987.T | Suzuken Co., Ltd. | $2.2B | 83 | Strong Buy |
| 2784.T | Alfresa Holdings Corporation | $2.5B | 83 | Strong Buy |
| 8129.T | Toho Holdings Co., Ltd. | $1.6B | 72 | Buy |
Peer medians: ROE 8.3% · P/E 16.6x · Gross margin 46.8%